Evaluating remission and low disease activity from the perspective of the patient with axial spondyloarthritis: The cross-sectional ConREspAx study - 05/03/23
Highlights |
• | This is the first study aiming to evaluate self-perceived remission in a group of patients with axial spondyloarthritis, and confirming the feasibility of such evaluation. |
• | Highest disagreement among all proposed definitions for remission was between patient and physician perception by a single question. |
• | The best agreement for patients’ perception of remission was found for a BASDAI < 2 and normal C-reactive protein values. |
Abstract |
Objectives |
To evaluate the properties of a single question to determine patient perception of remission and disease activity; to compare this with existing definitions for remission and low disease activity (LDA).
Methods |
Single-center, cross-sectional study in a tertiary care hospital. Patients with axSpA (fulfilling ASAS criteria) were consecutively included. Both the patient's perception of remission and LDA and that of the physician were evaluated with a single question. Agreement between the patients’ perception and other current definitions was tested using the prevalence-adjusted and bias-adjusted kappa (PABAK). The sensitivity (S) and specificity (Sp) of current definitions of disease states were tested against the patient's perception as the gold standard.
Results |
The study population included 105 axSpA patients (63.8% males; 67.6% with radiographic sacroiliitis). Patients considered themselves to be in remission in 21% of cases and in LDA in 51.4%; physicians considered patients to be in remission in 45.7% of cases and in LDA in 35.2%. The poorest agreement was recorded for the patient's and the physician's perception of remission. The best agreement for patients’ perception of remission was for a BASDAI < 2 and normal C-reactive protein values. This definition was also the most sensitive (S=72.7%) and specific (Sp=83.1%) when the patient's perception was taken as the gold standard.
Conclusion |
In a real-life setting, the evaluation of remission by the patient through a single question was the hardest criterion to achieve, although it did prove to be a feasible, valid, and specific way to assess remission.
Le texte complet de cet article est disponible en PDF.Keywords : Spondyloarthritis, Patient reported outcomes, Remission
Plan
Vol 90 - N° 2
Article 105505- mars 2023 Retour au numéro
Article précédent
- Risk of acute myocardial infarction, stroke, and venous thromboembolism among patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in South Korea: A nationwide population-based study
- Joong Kyong Ahn, Jiwon Hwang, Chan-Bum Choi, Gi Hyeon Seo
- Post-traumatic stress disorder prior to diagnosis is as rare in spondyloarthritis as in non-inflammatory rheumatic conditions and rheumatoid arthritis
- Angelique Fan, Baptiste Glace, Bruno Pereira, Sandrine Malochet-Guinamand, Marion Couderc, Sylvain Mathieu, Anne Tournadre, Martin Soubrier, Jean-Jacques Dubost
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?